SKI Market

Indian Indices

Sensex

78,918.90 -1,097.00
( -1.37%)

Global Indices

Nasdaq

47,518.20 -457.55
(-0.95%)

Dow Jones

6,761.35 -90.36
(-1.32%)

Hang Seng

55,600.46 322.40
(0.58%)

Nikkei 225

10,286.75 -127.19
(-1.22%)

Forex

USD-INR

91.74 -0.39
(-0.42%)

EUR-INR

106.47 -0.59
(-0.55%)

GBP-INR

122.42 -0.61
(-0.50%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

214.06

47.78

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

tata motors ltd

Trigyn Technologies consolidated net profit rises 1363.89% in the September 2025 quarter

Nov 15,2025

Net profit of Trigyn Technologies rose 1363.89% to Rs 5.27 crore in the quarter ended September 2025 as against Rs 0.36 crore during the previous quarter ended September 2024. Sales rose 16.43% to Rs 241.95 crore in the quarter ended September 2025 as against Rs 207.80 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	241.95	207.80	16
OPM %	0.91	2.10	-
PBDT	5.64	8.94	-37
PBT	4.78	7.47	-36
NP	5.27	0.36	1364

78,918.90 -1,097.00 ( -1.37%)

47,518.20 -457.55 (-0.95%)

6,761.35 -90.36 (-1.32%)

55,600.46 322.40 (0.58%)

10,286.75 -127.19 (-1.22%)

91.74 -0.39 (-0.42%)

106.47 -0.59 (-0.55%)

122.42 -0.61 (-0.50%)

0.58 0.00 (-0.46%)